Life Science

The Life Science team develops new technologies to improve people’s well-being and health through light. Our most recent activities are in the field of photobiomodulation — the utilization of red and near-infrared light to trigger photochemical effects in cells. These photochemical effects can cause a major positive impact on people's health and well-being.

Seaborough Life Science

Seaborough Life Science invents and develops lighting technologies to improve people’s well-being and health. We develop materials to enable novel light therapies to treat skin diseases and we conduct groundbreaking long-term research in the field of photobiomodulation.

Light therapy

Light is a vital source to life and to human health and wellbeing, just like food, water and air. The human body – and in particular the skin and the eyes – interacts in many different ways with light. Sunlight is essential for vitamin D3 generation in the skin, important for optimal health and associated with many health aspects. Light also strongly influences our circadian rhythm, which helps us sleep and recover well, physically and mentally.
Light therapy on the skin can be used to treat skin disorders, such as psoriasis, acne, eczema and neonatal jaundice. Light can be used effectively to treat and prevent seasonal affective disorder, and potentially other psychiatric disorders too. Red and near-infrared light can be used to reduce pain and accelerate wound healing and potentially much more, as we are researching in our current clinical trial.
Building on these proven therapies, Seaborough is constantly looking for new technologies in the field of lighting that contribute to human health and wellbeing.


Our People

Mike Krames

Senior Advisor

Mike is a recognized world authority on visible-spectrum LEDs and their applications for lighting and displays, with more than 20 years of experience in both startups and large companies in the LED industry. He is currently President and Founder of Arkesso, LLC, based in Silicon Valley, California.  Previously, he was Chief Technology Officer at Soraa, Inc., an LED product company founded by Nobel Prize winner Shuji Nakamura.  Prior to that, he was Executive Vice President at Philips Lumileds, where he ran the Advanced Laboratories and pioneered programs in LEDs and luminescence, focusing on materials, devices, and systems for applications to lighting and displays. He has served on numerous roundtables and panels for the U.S. Department of Energy and Basic Energy Sciences. He is an IEEE Fellow, IES Fellow and Chair of the SPIE Photonics West Conference on Light-Emitting Diodes.

He has been an advisor to Seaborough since 2015, where he is supporting technical and intellectual property development, project management, business development and the establishment of new partnerships.

Charlie Minter

Program Director Life Science

Charlie is an engineer/designer/architect with experience in product development, manufacturing, electronics, ecological design, (landscape) architecture and, in general, making teams work and work fun. Wide range of interests ranging from visual arts to music to food to meditation to computer programming. He loves to work with a team on projects that make this world an even better place.

What we are working on

Clinical trial
Clinical trial
Market-ready prototype